Table 1.
Characteristics of the study population.
| n = 1,201 | |
|---|---|
| Age (years) | 53.6 ± 9.3 |
| Gender (men, %) | 576 (48) |
| BMI (kg/m2) | 28.5 ± 4.5 |
| Visceral AT (cm2) | 151 (112–194) |
| Systolic blood pressure (mmHg) | 118 ± 18 |
| Diastolic blood pressure (mmHg) | 72 ± 10 |
| LDL-C (mmol/L) | 3.08 ± 0.83 |
| HDL-C (mmol/L) | 1.19 ± 0.34 |
| Triglycerides (mmol/L) | 1.68 (1.28–2.28) |
| Fasting glucose (mmol/L) | 5.05 (4.7–5.5) |
| HOMA-IR | 4.09 (2.7–5.9) |
| Adipo-IR | 9.65 (6.24 − 14.49) |
| hsCRP (nmol/L) | 15.3 (8.2–32.0) |
| Adiponectin (μg/mL) | 7.9 (4.9–12.8) |
| Physical activity index | 7.88 ± 1.22 |
| Current smoking, n (%) | 270 (22.5) |
| Statin use, n (%) | 106 (8.8) |
| Type 2 diabetes, n (%) | 161 (13.4) |
| Coronary artery calcification, n (%) | 318 (26.5) |
| Aortic valve calcification, n (%) | 226 (18.8) |
Values of quantitative variables are expressed as mean ± standard deviation or median (interquartile range) and qualitative variables as number of subjects (percentage). BMI: body mass index; AT: adipose tissue; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; Adipo-IR: adipose tissue insulin resistance; hsCRP: high sensitive C-reactive protein.